According to a new article published in the May 12 issue of Cancer Cell, researchers believe that they have been able to identify a specific combination of two genes that, acting synergistically, may be the drivers behind some aggressive subtypes of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: aggressive, CENPF, FOXM1, genes | 1 Comment »
According to a media release this morning from Genomic Health, Inc., initial data from a large study has identified 295 genes that are strongly associated with clinical recurrence following radical prostatectomy. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: genes, localized, progression, recurrence, test | 1 Comment »
According to a media release from Myriad Genetics, the company’s investigational genetic test (Prolaris™) can accurately predict prostate cancer-specific mortality at 10 years in men known to have clinically localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: cancer-specific, genes, mortality, prognosis, PROLARIS, test | 4 Comments »
Over the past few months, the US Food and Drug Administration (FDA) has issued a slew of letters to companies marketing tests designed to provide consumers with information about their genetic profile and their risks for certain types of disease. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: genes, genetics, risk, test | 4 Comments »
Today being December 31, this will be the final daily news report of the first calendar year of existence for The “New” Prostate Cancer InfoLink.
There are three reports covered in the news below, the most important of which supports the idea that men with diabetes have a reduced risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk, Treatment | Tagged: conformal arc, diabetes, genes, image-guided, radiotherapy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 